Dr. Fogarty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2030 N Church Place
Spartanburg, SC 29303Phone+1 864-558-2685Fax+1 864-585-0999
Education & Training
- University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1975 - 1977
- University of RochesterResidency, Internal Medicine, 1973 - 1975
- University of RochesterInternship, Internal Medicine, 1970 - 1971
- University of Rochester School of Medicine and DentistryClass of 1970
Certifications & Licensure
- NY State Medical License 1971 - Present
- SC State Medical License 1978 - 2025
- PA State Medical License 1975 - 1978
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects Start of enrollment: 2014 Mar 01
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 1 citationsEffect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, plac...Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling
The Lancet. Respiratory Medicine. 2025-02-10 - 3 citationsA Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).Susanna K Tan, Deborah Cebrik, David Plotnik, Maria L Agostini, Keith Boundy
Clinical Infectious Diseases. 2024-10-15 - 52 citationsSafety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen
The Journal of Infectious Diseases. 2023-03-28
Journal Articles
- Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older AdultsCharles Fogarty, MD, JAMA Network Open
- The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults: An Open Phase III TrialMyron J Levin, David Butuk, Kenneth E Schmader, Charles Fogarty, Paul Hartley, Max Nevarez, Nicola P Klein, Kari Uusinarkaus, The Journals of Gerontology
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: